Tumor growth is associated with profound metabolic and neurochemical alterations, which can lead to the onset of anorexia−cachexia syndrome. Anorexia is defined as the loss of the desire to eat, while ...
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, ...
A recent Nature Metabolism study reports that circulating lactate levels are positively associated with weight loss in cancer cachexia patients. Mouse model experiments also revealed that ...
Inflammatory marker levels and prediction of patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy. This is an ASCO Meeting Abstract from the ...
Up to 80 percent of patients with cancer struggle with cachexia, often called wasting syndrome, which is a condition characterized by the inability to gain or maintain body weight. One of the reasons ...
Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, ...
Primary prevention of venous thromboembolic events (VTE) in cancer patients: An American survey study This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include ...
Z526- a novel dithiocarbamate-like compound reverses cancer associated cachexia via mitigating NF-κB signaling and oxidative stress. In a recent study, researchers demonstrated that Z526, a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results